Downregulation in the mRNA expression of nuclear hormone receptor liver-X-receptor alpha (LXR-α) by TNF-α is abolished by the antioxidant kaempferol, but not ascorbic acid, in human hepatocarcinoma HepG2 cells

1. Hashimoto K, Matsumoto S, Yamada M, Satoh T, Mori M. Liver X Receptor-α gene expression is positively regulated by thyroid hormone. Endocrinology. 2007; 148:4667-75.10.1210/en.2007-015017628006Search in Google Scholar

2. Zelcer N, Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signalling. J Clin Invest. 2006; 116:607-14.10.1172/JCI27883138611516511593Open DOISearch in Google Scholar

3. Jamroz-Wioeniewska A, Wójcicka G, Horoszewicz K, Be³towski J. Liver X receptors (LXRs). Part II: Nonlipid effects, role in pathology, and therapeutic implications. Postepy Hig Med Dosw. 2007; 61:760-85.Search in Google Scholar

4. Gerbod-Giannone M, Li Y, Holleboom A, Han S, Hsu L, Tabas I, et al. TNF-α induces ABCA1 through NF-κB in macrophages and in phagocytes ingesting apoptotic cells. Proc Natl Acad Sci U S A. 2006; 103:3112-7.10.1073/pnas.0510345103141389716492740Open DOISearch in Google Scholar

5. Tacer KF, Kuzman D, Seliskar M, Pompon D, Rozman D. TNF-α interferes with lipid homeostasis and activates acute and proatherogenic processes. Physiol Genomics. 2007; 31:216-27.10.1152/physiolgenomics.00264.200617566076Open DOISearch in Google Scholar

6. Kwon SH, Nam JI, Kim SH, Kim JH, Yoon JH, Kim KS. Kaempferol and quercetin, essential ingredients in ginkgo biloba extract, inhibit interleukin-1β-induced MUC5AC gene expression in human airway epithelial cells. Phytother Res. 2009; 23:1708-12.10.1002/ptr.281719367675Open DOISearch in Google Scholar

7. Arai H, Uchida K, Nakamura K. Effect of ascorbate on acrolein modification of very low density lipoprotein and uptake of oxidized apolipoprotein E by hepatocytes. Biosci Biotech Bioch. 2005; 69:1760-2.10.1271/bbb.69.176016195596Open DOISearch in Google Scholar

8. Garcia-Lafuente A, Guillamon E, Villares A, Rostagno MA, Martinez JA. Flavonoids as anti-inflammatory agents: Implications in cancer and cardiovascular disease. Inflamm Res. 2009; 58:537-52.10.1007/s00011-009-0037-319381780Open DOISearch in Google Scholar

9. Wang Y, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Downregulation of liver X receptor-α in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines. J Lipid Res. 2005; 46:2377-87.10.1194/jlr.M500134-JLR20016106051Open DOISearch in Google Scholar

10. Ng DL, Tie SW, Ong PC, Lim WS, Tengku-Muhammad TS, Choo, QC, Chew CH. Rapamycin pre-treatment abrogates Tumour Necrosis Factor-α down-regulatory effects on LXR-α and PXR mRNA expression via inhibition of c-Jun N-terminal kinase 1 activation in HepG2 cells [Internet]. Electron J Biotechn. 2011; 14. Available from http://www.ejbiotechnology.info/index.php/ejbiotechnology/article/viewFile/v14n3-9/ 1296 DOI:10.2225/vol14-issue3-fulltext-910.2225/vol14-issue3-fulltext-9Open DOISearch in Google Scholar

11. Kim HK, Park HR, Lee JS, Chung TS, Chung HY, Chung J. Down-regulation of iNOS and TNF-α expression by kaempferol via NF-κB inactivation in aged rat gingival tissues. Biogerontology. 2007; 8: 399-408.10.1007/s10522-007-9083-917278014Open DOISearch in Google Scholar

12. Hämalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007; 2007: 45673.10.1155/2007/45673Search in Google Scholar

13. Gomes A, Fernandes E, Lima JLFC, Mira L, Corvo ML. Molecular mechanisms of anti-inflammatory activity mediated by flavonoids. Curr Med Chem. 2008; 15: 1586-605.10.2174/092986708784911579Open DOISearch in Google Scholar

14. Bowie AG, O’Neill LAJ. Vitamin C inhibits NF-κB activation by TNF via the activation of p38 mitogenactivated protein kinase. J Immunol. 2000; 165:7180-8.10.4049/jimmunol.165.12.7180Search in Google Scholar

15. Mu oz E, Bl zquez MV, Ortiz C, Gomez-Di z C, Navas P. Role of ascorbate in the activation of NF-κB by tumor necrosis factor-α in T-cells. Biochem J. 1997; 325:23-8.10.1042/bj3250023Search in Google Scholar

16. Kaul D, Baba M. Genomic effect of vitamin ‘C’ and statins within human mononuclear cells involved in atherogenic process. Eur J Clin Nutr. 2005; 59:978-81.10.1038/sj.ejcn.1602203Open DOISearch in Google Scholar

17. Kaya F, Belin S, Bourgeois P, Micaleff J, Blin O, Fontes M. Ascorbic acid inhibits PMP22 expression by reducing cAMP levels. Neuromuscul Disord. 2007; 17: 248-53.10.1016/j.nmd.2006.12.008Open DOISearch in Google Scholar

18. McRae MP. The efficacy of vitamin C supplementation on reducing total serum cholesterol in human subjects: a review and analysis of 51 experimental trials. J Chiropr Med. 2006; 5:2-12.10.1016/S0899-3467(07)60127-XOpen DOISearch in Google Scholar

19. Aulinskas TH, Van der Westhuyzen DR, Coetzee GA. Ascorbate increases the number of low density lipoprotein receptors in cultured arterial smooth muscle cells. Atherosclerosis 1983; 47:159-71.10.1016/0021-9150(83)90152-1Open DOISearch in Google Scholar

20. Laffitte BA, Joseph SB, Walczak R, Pei L, Wilpitz DC, Collins JL, et al. Autoregulation of the human liver X receptor α promoter. Mol Cell Biol. 2001; 21:7558-68. 10.1128/MCB.21.22.7558-7568.20019992711604492Open DOISearch in Google Scholar